Other OTC - Delayed Quote • USD
Roche Holding AG (RHHBY)
At close: May 16 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | 0 | 0 | 2.65 | 2.84 |
| Low Estimate | 0 | 0 | 2.44 | 2.56 |
| High Estimate | 0 | 0 | 2.95 | 3.15 |
| Year Ago EPS | -- | -- | 2.58 | 2.65 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 4 | 4 |
| Avg. Estimate | -- | -- | 66.54B | 69.64B |
| Low Estimate | -- | -- | 64.52B | 67.27B |
| High Estimate | -- | -- | 68.98B | 73.2B |
| Year Ago Sales | -- | -- | 65.36B | 66.54B |
| Sales Growth (year/est) | -- | -- | 1.80% | 4.70% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 2.65 | 2.84 |
| 7 Days Ago | 0 | 0 | 2.65 | 2.84 |
| 30 Days Ago | 0 | 0 | 2.63 | 2.82 |
| 60 Days Ago | 0 | 0 | 2.67 | 2.87 |
| 90 Days Ago | 0 | 0 | 2.5 | 2.65 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | RHHBY | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 7.20% |
| Next Qtr. | -- | -- | -- | 11.30% |
| Current Year | 2.70% | -- | -- | 4.60% |
| Next Year | 7.20% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 4.30% | -- | -- | 10.96% |
| Past 5 Years (per annum) | 4.84% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | TD Cowen: Market Perform to Market Perform | 9/12/2023 |
| Downgrade | Cowen & Co.: Outperform to Market Perform | 11/15/2022 |
| Maintains | Cowen & Co.: Outperform | 6/27/2022 |
| Upgrade | Deutsche Bank: Hold to Buy | 7/8/2021 |
| Initiated | Argus Research: Buy | 1/28/2019 |
| Upgrade | Credit Suisse: Underperform to Neutral | 1/28/2019 |
Related Tickers
NVS Novartis AG
102.69
-0.51%
GSK GSK plc
44.88
-0.98%
AZN AstraZeneca PLC
77.04
+0.09%
SNY Sanofi
48.82
-0.39%
BAYRY Bayer Aktiengesellschaft
7.77
-3.06%
BIIB Biogen Inc.
230.04
-2.24%
GILD Gilead Sciences, Inc.
67.86
+1.27%
MRK Merck & Co., Inc.
130.88
-0.65%
AMGN Amgen Inc.
314.72
-0.65%
BMY Bristol-Myers Squibb Company
44.11
-0.99%